121P MK-7684A (vibostolimab [vibo] plus pembrolizumab [pembro] coformulation) with/without docetaxel in metastatic NSCLC after platinum-chemotherapy (chemo) and immunotherapy

Saved in:
Bibliographic Details
Published in:Immuno-oncology technology 2023-12, Vol.20, p.100593, Article 100593
Main Authors: Peled, N., Mazieres, J., Kowalski, D.M., Lam, W-S., Hochmair, M.J., Majem, M., Kim, S.H., Blanco, A. Calles, Cuppens, K., Casarini, I.A., Bylicki, O., Shim, B., Sørensen, J.B., Gilli, M., How, S.H., Schumann, C., Gonzalez Arenas, C., He, T., Samkari, A., Novello, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2590-0188
2590-0188
DOI:10.1016/j.iotech.2023.100593